Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities-Reference-Cited by-同舟云学术

Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities

Published:1999-08 Issue:2 Volume:54 Page:313-318
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Akakura Koichiro,Isaka Shigeo,Akimoto Susumu,Ito Haruo,Okada Kiyoki,Hachiya Takahiko,Yoshida Osamu,Arai Yoichi,Usami Michiyuki,Kotake Toshihiko,Tobisu Ken-Ichi,Ohashi Yasuo,Sumiyoshi Yoshiteru,Kakizoe Tadao,Shimazaki Jun

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Results of radical prostatectomy in men with clinically localized prostate cancer;Gerber;JAMA,1996

2. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up;Epstein;Am J Surg Pathol,1996

3. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer;Catalona;J Urol,1994

4. Experience with radical prostatectomy and radiation therapy for localized prostate cancer at a Veterans Affairs Medical Center;Fowler;J Urol,1995

5. Control of prostate cancer with radiotherapy;Bagshaw;J Urol,1994

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer;Clinical Genitourinary Cancer;2024-10

3. The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis;Asian Journal of Andrology;2020

4. Treatment of locally advanced prostate cancer (Stage T3);Japanese Journal of Clinical Oncology;2017-01-17

5. Outcome of radical prostatectomy as primary treatment for high-risk prostate cancer patients;Indian Journal of Cancer;2015